Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01250223 · ClinicalTrials.gov registry record
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
A clinical trial, sponsored by Associazione Angela Serra per la ricerca sul cancro.
- Completed
- Registry status
- 1,093
- Enrollment target
NCT01250223 is a clinical trial that has completed, run by Associazione Angela Serra per la ricerca sul cancro. The registered enrollment target is 1,093 participants.
The verdict
NCT01250223 has completed, sponsored by Associazione Angela Serra per la ricerca sul cancro.
- COMPLETED
- Registry status
- 1,093 participants
- Enrollment target
Study Summary
The F2-study is a complement of the previous studies of the Follicular Lymphoma Prognostic Factors Project which permitted the development of the Follicular Lymphoma International Prognostic Index (FLIPI). The F2-study is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed Follicular Lymphoma patients, and its purposes are to validate the FLIPI and to verify whether a prognostic collection of data would allow the development of a more accurate prognostic index.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,093 participants |
| Start Date | 2003-02 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01250223
The ClinicalTrials.gov registry entry for NCT01250223 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,093 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Associazione Angela Serra per la ricerca sul cancro, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01250223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01250223 about?
NCT01250223 is a clinical study titled "Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)". The F2-study is a complement of the previous studies of the Follicular Lymphoma Prognostic Factors Project which permitted the development of the Follicular Lymphoma International Prognostic Index (FLIPI). The F2-study is designed as a prospective collection of information potentially useful to pre...
What is the current status of trial NCT01250223?
This trial is currently completed. The enrollment target is 1,093 participants. The study started on 2003-02. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT01250223?
This trial is sponsored by Associazione Angela Serra per la ricerca sul cancro, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.